Lonestar Heart
Laguna Hills, California, United States
About Lonestar Heart
LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF). Based on its integrated card mechanical and biomolecular technologies, the privately-held company is developing a broad portfolio of products to restore the failing heart’s structure and function in collaboration with the University of Texas Southwestern Medical Center, Texas Heart Institute, and a global network of leading clinicians. These products include Algisyl-LVR, small molecule cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the company’s proprietary biopolymer hydrogel matrix system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $47.1M
- Funding stage: Late Stage Venture
- Last round: Debt Financing (Sep 2014)
- Website: lonestarheartinc.com
- Phone: (949) 215-3613
Industries & Categories
Biotechnology, Genetics, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lonestar-heart-2492044 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.